KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Other Non Operating Income (2016 - 2025)

AbbVie (ABBV) has disclosed Other Non Operating Income for 14 consecutive years, with -$5.7 billion as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income fell 30142.11% to -$5.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$9.8 billion through Dec 2025, down 1532.84% year-over-year, with the annual reading at -$5.8 billion for FY2025, 27485.71% down from the prior year.
  • Other Non Operating Income for Q4 2025 was -$5.7 billion at AbbVie, down from -$20.0 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $3.0 billion in Q4 2023, with the low at -$5.7 billion in Q4 2025.
  • Average Other Non Operating Income over 5 years is -$474.0 million, with a median of -$19.5 million recorded in 2024.
  • The sharpest move saw Other Non Operating Income soared 8722.22% in 2022, then tumbled 263800.0% in 2025.
  • Over 5 years, Other Non Operating Income stood at $2.2 billion in 2021, then crashed by 190.51% to -$2.0 billion in 2022, then skyrocketed by 247.2% to $3.0 billion in 2023, then crashed by 100.64% to -$19.0 million in 2024, then plummeted by 30142.11% to -$5.7 billion in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at -$5.7 billion, -$20.0 million, and -$2.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.